Hanafy Hafez

465 total citations
32 papers, 262 citations indexed

About

Hanafy Hafez is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Hanafy Hafez has authored 32 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Hanafy Hafez's work include Neutropenia and Cancer Infections (9 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (7 papers). Hanafy Hafez is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (7 papers). Hanafy Hafez collaborates with scholars based in Egypt, United States and India. Hanafy Hafez's co-authors include M. M. Lubani, I Helin, Q. A. Al-Saleh, George F. Araj, M. Salhi, D. C. Sharda, Alaa Elhaddad, Lobna Shalaby, Leslie Lehmann and Mahmoud Hammad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Oncology.

In The Last Decade

Hanafy Hafez

29 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanafy Hafez Egypt 9 90 81 61 41 36 32 262
Depei Wu China 10 189 2.1× 27 0.3× 85 1.4× 33 0.8× 194 5.4× 28 313
Charles M. Noyer United States 10 50 0.6× 27 0.3× 12 0.2× 45 1.1× 39 1.1× 19 318
Angela Haßler Germany 8 225 2.5× 13 0.2× 60 1.0× 11 0.3× 103 2.9× 9 377
M J Smith United Kingdom 6 147 1.6× 46 0.6× 21 0.3× 32 0.8× 103 2.9× 7 342
Virginie Gandemer France 6 243 2.7× 45 0.6× 42 0.7× 15 0.4× 267 7.4× 17 457
P. M. Flynn United States 6 223 2.5× 23 0.3× 167 2.7× 18 0.4× 196 5.4× 8 408
Emma Paige Australia 8 151 1.7× 44 0.5× 30 0.5× 23 0.6× 109 3.0× 11 278
Refaat Kamel Egypt 11 192 2.1× 21 0.3× 25 0.4× 79 1.9× 34 0.9× 28 500
Maher Osman Denmark 10 58 0.6× 14 0.2× 129 2.1× 28 0.7× 40 1.1× 21 399
Taweesak Tongtawee Thailand 13 47 0.5× 65 0.8× 65 1.1× 58 1.4× 14 0.4× 47 438

Countries citing papers authored by Hanafy Hafez

Since Specialization
Citations

This map shows the geographic impact of Hanafy Hafez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanafy Hafez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanafy Hafez more than expected).

Fields of papers citing papers by Hanafy Hafez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanafy Hafez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanafy Hafez. The network helps show where Hanafy Hafez may publish in the future.

Co-authorship network of co-authors of Hanafy Hafez

This figure shows the co-authorship network connecting the top 25 collaborators of Hanafy Hafez. A scholar is included among the top collaborators of Hanafy Hafez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanafy Hafez. Hanafy Hafez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammad, Mahmoud, et al.. (2024). CT-473 Impact of Donor Lymphocyte Infusion on Outcomes of Myeloid Neoplasms Post Allogeneic Stem Cell Transplantation, Single Center Experience. Clinical Lymphoma Myeloma & Leukemia. 24. S606–S607. 1 indexed citations
2.
3.
Hafez, Hanafy, et al.. (2024). Patterns of expression of VEGFR2, PDGFRs and c-Kit in pediatric patients with high grade non-rhabdomyosarcoma soft tissue sarcoma. Frontiers in Oncology. 14. 1480773–1480773. 2 indexed citations
4.
Khedr, Reham, et al.. (2023). Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome. Antibiotics. 12(2). 405–405. 7 indexed citations
5.
6.
7.
Hafez, Hanafy, et al.. (2022). ALL-204 Barriers to Improving Outcomes of Children With Acute Lymphoblastic Leukemia in Low- to Middle-Income Countries. Clinical Lymphoma Myeloma & Leukemia. 22. S195–S195. 1 indexed citations
8.
9.
Hafez, Hanafy, et al.. (2020). Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single‐center experience. Pediatric Transplantation. 24(4). e13664–e13664. 4 indexed citations
10.
11.
12.
13.
Hammad, Mahmoud, Hanafy Hafez, Mohamed S. Zaghloul, et al.. (2019). Outcome predictors of autologous hematopoietic stem cell transplantation in children with relapsed and refractory Hodgkin lymphoma: Single‐center experience in a lower‐middle‐income country. Pediatric Transplantation. 23(6). e13531–e13531. 5 indexed citations
14.
Khedr, Reham, et al.. (2019). Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt. Mycoses. 62(11). 984–989. 14 indexed citations
15.
Hafez, Hanafy, et al.. (2019). Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 19(5). e221–e227. 2 indexed citations
16.
Khedr, Reham, et al.. (2017). Mucormycosis the Emerging Global Threat; Overview and Treatment Outcome Among Pediatric Cancer Patients in Egypt. Blood. 130. 4830–4830. 6 indexed citations
17.
Hafez, Hanafy, et al.. (2017). Surgical approaches, anaesthetic management and outcome in pediatric superior mediastinal tumors. Journal of the Egyptian National Cancer Institute. 29(3). 147–153. 4 indexed citations
18.
Hafez, Hanafy, et al.. (2016). Early Deaths in Pediatric Acute Leukemia; A Challenge in Developing Countries. Blood. 128(22). 5160–5160. 2 indexed citations
19.
Fawzy, Mohamed, et al.. (2015). Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World. Pediatric Hematology and Oncology. 32(8). 548–556. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Depei Wu Breakdown of academic impact, for papers by Charles M. Noyer Breakdown of academic impact, for papers by Angela Haßler Breakdown of academic impact, for papers by M J Smith Breakdown of academic impact, for papers by Virginie Gandemer Breakdown of academic impact, for papers by P. M. Flynn Breakdown of academic impact, for papers by Emma Paige Breakdown of academic impact, for papers by Refaat Kamel Breakdown of academic impact, for papers by Maher Osman Breakdown of academic impact, for papers by Taweesak Tongtawee
Rankless by CCL
2026